News

Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
CNN4y
Moderna’s coronavirus vaccine is 94.5% effective, according to ... - CNN
The Moderna vaccine is 94.5% effective against coronavirus, according to early data released Monday by the company, making it the second vaccine in the United States to have a stunningly high ...
USA Today4y
COVID vaccine from Moderna, Pfizer, AstraZeneca: What's the difference
Moderna has received nearly $2.5 billion from U.S. taxpayers to develop, manufacture and distribute its vaccine; while Pfizer/BioNTech has been promised just under $2 billion for manufacturing and ...
ABC News3y
Why Moderna says its vaccine efficacy in children is better than it ...
The Moderna Covid-19 vaccine awaits administration at a vaccination clinic in Los Angeles, Dec. 15, 2021. AFP via Getty Images, FILE. Moderna's bid for FDA authorization for its two-dose ...
CNN3y
Moderna’s vaccine is the most effective, but Pfizer and J&J also ...
A head-to-head study of coronavirus vaccines in the United States finds the Moderna vaccine is slightly more effective than Pfizer’s in real-life use in keeping people out of the hospital, and J ...
Moderna stock rallies on HHS lawsuit news: analyst says negative sentiment reversing
Moderna shares surged 9.5% amid legal backlash against vaccine policy changes. Will it be a turning point for MRNA which is ...
Moderna (MRNA) Jumps 8.8% on COVID-19 Support from Medical Organizations
Moderna Inc. jumped by 8.83 percent on Tuesday to close at $32.54 apiece as investor sentiment was boosted by a lawsuit filed ...
Barchart on MSN3d
The Next Moderna? This Clinical-Stage Biotech Has Breakout Potential.
Moderna (MRNA), an undervalued name in the biotech space, rose to prominence during the COVID-19 pandemic. This occurred when ...